No CrossRef data available.
Article contents
Does conflict of interest impact speaker credibility?
Published online by Cambridge University Press: 21 May 2015
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Commentary • Commentaire
- Information
- Copyright
- Copyright © Canadian Association of Emergency Physicians 2001
References
1.Reeder, M, Dougherty, J, White, LJ.Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med 1993;22(10):1593–6.Google Scholar
2.Girard, DE.The relationship between physicians in training and pharmaceutical companies: A time for guidelines? Arch Intern Med 1992;152(5):920–1.CrossRefGoogle ScholarPubMed
3.Rosner, F.Pharmaceutical industry support for continuing medical education programs: a review of current ethical guidelines. Mt Sinai J Med 1995;62(6):427–30.Google ScholarPubMed
4.Wazana, A.Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 2000;283(3):373–80.CrossRefGoogle ScholarPubMed
5.American Medical Association. AMA ethical opinions on CME. In: CME resource guide. Available: www.ama-assn.org/cmeselec/cmeres/cme-6.htm (accessed 2001 Apr 12).Google Scholar
6.Ryan, TJ, Anderson, JL, Antman, EM, Braniff, BA, Brooks, NH, Califf, RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996;28(5): 1328–428.Google Scholar
7.Spingarn, RW, Berlin, JA, Strom, BL.When pharmaceutical manufacturers’ employees present grand rounds, what do residents remember? Acad Med 1996;71(1):86–8.CrossRefGoogle ScholarPubMed
You have
Access